S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon

Hepion Pharmaceuticals (HEPA) Insider Trading & Ownership

$2.01
-0.10 (-4.74%)
(As of 04/19/2024 ET)

Hepion Pharmaceuticals (NASDAQ:HEPA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.95%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$49,790.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get HEPA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HEPA Insider Buying and Selling by Quarter

Hepion Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/27/2023Peter WijngaardDirectorBuy2,500$3.05$7,625.00  
11/24/2023Peter WijngaardDirectorBuy2,500$3.09$7,725.00  
9/19/2023Peter WijngaardDirectorBuy1,000$5.64$5,640.00  
9/18/2023Robert T FosterCEOBuy1,600$5.60$8,960.00  
9/15/2023Peter WijngaardDirectorBuy2,000$5.60$11,200.00  
9/15/2023Robert T FosterCEOBuy1,600$5.40$8,640.00  
(Data available from 1/1/2013 forward)

HEPA Insider Trading Activity - Frequently Asked Questions

Who is on Hepion Pharmaceuticals's Insider Roster?

The list of insiders at Hepion Pharmaceuticals includes Peter Wijngaard, and Robert T Foster. Learn more on insiders at HEPA.

What percentage of Hepion Pharmaceuticals stock is owned by insiders?

1.95% of Hepion Pharmaceuticals stock is owned by insiders. Learn more on HEPA's insider holdings.

Which Hepion Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased HEPA shares in the last 24 months: Peter Wijngaard ($32,190.00), and Robert T Foster ($17,600.00).

How much insider buying is happening at Hepion Pharmaceuticals?

Insiders have purchased a total of 11,200 HEPA shares in the last 24 months for a total of $49,790.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:HEPA) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners